Literature DB >> 12206286

Serotyping discrepancies in Haemophilus influenzae type b disease--United States, 1998-1999.

.   

Abstract

Since Haemophilus influenzae type b (Hib) conjugate vaccines were introduced in the United States in 1990, the incidence of Hib invasive disease has declined markedly. The majority of cases of Haemophilus influenzae (Hi) disease are caused by organisms with capsule types other than b or by nontypeable organisms. One of the national health objectives for 2010 is to reduce to zero indigenous Hib invasive disease cases in children aged <5 years (objective 14-1c). In 2000, a total of 297 cases of invasive Hi disease were reported in children aged <5 years; serotype b represented 51 (22%) of 236 cases for which serotype information was known. This report describes inconsistencies in Hib serotyping between state health departments and CDC; these inconsistencies suggest that the burden of Hib disease might be less than estimated previously. Accurate laboratory information is essential for the accurate assessment of progress toward the elimination of Hib in the United States.

Entities:  

Mesh:

Year:  2002        PMID: 12206286

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  9 in total

Review 1.  Haemophilus influenzae type a infection and its prevention.

Authors:  Zhigang Jin; Sandra Romero-Steiner; George M Carlone; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2007-03-12       Impact factor: 3.441

2.  Invasive Haemophilus influenzae in Manitoba, Canada, in the postvaccination era.

Authors:  Raymond S W Tsang; Samira Mubareka; Michelle L Sill; John Wylie; Stuart Skinner; Dennis K S Law
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  Characterisation of invasive Haemophilus influenzae isolates in Slovenia, 1993-2008.

Authors:  T Kastrin; M Paragi; J Kolman; M Cizman; A Kraigher; M Gubina
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-21       Impact factor: 3.267

4.  International circumpolar surveillance interlaboratory quality control program for serotyping Haemophilus influenzae and serogrouping Neisseria meningitidis, 2005 to 2009.

Authors:  Raymond S W Tsang; Karen Rudolph; Marguerite Lovgren; Sadjia Bekal; Brigitte Lefebvre; Lotte Lambertsen; Tammy Zulz; Michael Bruce
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

5.  Use of bexB to detect the capsule locus in Haemophilus influenzae.

Authors:  Gregg S Davis; Sara A Sandstedt; Mayuri Patel; Carl F Marrs; Janet R Gilsdorf
Journal:  J Clin Microbiol       Date:  2011-04-27       Impact factor: 5.948

6.  Genotypic characteristics of Haemophilus influenzae isolates from pediatric pneumonia patients in Chengdu city, Sichuan, China.

Authors:  Guozhong Tian; Li Zhang; Machao Li; Xiaolei Wang; Yuhong Zheng; Xiaojing Li; Cheng Huang; Xuechun Li; Yongqiong Xie; Li Xu; Hongyu Ren; Zhujun Shao
Journal:  J Microbiol       Date:  2009-09-09       Impact factor: 3.422

7.  Action for child survival: elimination of Haemophilus influenzae type b meningitis in Uganda.

Authors:  Rosamund F Lewis; Annet Kisakye; Bradford D Gessner; Chaplain Duku; John Bosco Odipio; Robert Iriso; Denis Nansera; Fiona Braka; Issa Makumbi; Addy Kekitiinwa
Journal:  Bull World Health Organ       Date:  2008-04       Impact factor: 9.408

8.  Capsule gene analysis of invasive Haemophilus influenzae: accuracy of serotyping and prevalence of IS1016 among nontypeable isolates.

Authors:  Sarah W Satola; Julie T Collins; Ruth Napier; Monica M Farley
Journal:  J Clin Microbiol       Date:  2007-08-15       Impact factor: 5.948

9.  Molecular epidemiology of Haemophilus influenzae type b isolated from children with clinical cases of conjugate vaccine failures.

Authors:  José Campos; Belén Aracil; Federico Román; María Pérez-Vázquez
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.